A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5421-5428

  Buhlmann, Janet E ^a   Elkin, Sheryl Krevsky ^b   Sharpe, Arlene H ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; SUPERANTIGEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 0037514517     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5421     Document Type: Article

References (52)

1. Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M. F. Bachmann, and P. S. Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17:829.
2. + thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179:709.
3. Amsen, D., and A. M. Kruisbeek. 1996. CD28-B7 interactions function to costimulate clonal deletion of double-positive thymocytes. Int. Immunol. 8:1927.
4. + thymocytes by two distinct mechanisms differing in their requirement for CD28 costimulation: implications for negative selection in the thymus. J. Exp. Med. 186:1911.
5. Noel, P. J., M. L. Alegre, S. L. Reiner, and C. B. Thompson. 1998. Impaired negative selection in CD28-deficient mice. Cell. Immunol. 187:131.
6. Kishimoto, H., and J. Sprent. 1999. Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190:65.
7. Li, R., and D. M. Page. 2001. Requirement for a complex array of costimulators in the negative selection of autoreactive thymocytes in vivo. J. Immunol. 166:6050.
8. + thymocytes. J. Immunol. 149:3217.
9. + thymocytes. J. Immunol. 151:1868.
10. Dautigny, N., A. Le Campion, and B. Lucas. 1999. Timing and casting for actors of thymic negative selection. J. Immunol. 162:1294.
11. Walunas, T. L., A. I. Sperling, R. Khattri, C. B. Thompson, and J. A. Bluestone. 1996. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance. J. Immunol. 156:1006.
12. Waterhouse, P., M. F. Bachmann, J. M. Penninger, P. S. Ohashi, and T. W. Mak: 1997. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27:1887.
13. Chambers, C. A., D. Cado, T. Truong, and J. P. Allison. 1997. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94:9296.
14. Cilio, C. M., M. R. Daws, A. Malashicheva, C. L. Sentman, and D. Holmberg. 1998. Cytotoxic T lymphocyte antigen 4 is induced in the thymus upon in vivo activation and its blockade prevents anti-CD3-mediated depletion of thymocytes. J. Exp. Med. 188:1239.
15. + thymocytes. J. Immunol. 152:3254.
16. Kishimoto, H., Z. Cai, A. Brunmark, M. R. Jackson, P. A. Peterson, and J. Sprent. 1996. Differing roles for B7 and intercellular adhesion molecule-1 in negative selection of thymocytes. J. Exp. Med. 184:531.
17. Aoki, N., M. Inobe, M. Murakami, R. Abe, and H. Iizuka. 1998. The functional role of B7 molecules on the induction of thymocyte activation and apoptosis. Microbiol. Immunol. 42:555.
18. Page, D. M. 1999. Cutting edge: thymic selection and autoreactivity are regulated by multiple coreceptors involved in T cell activation. J. Immunol. 163:3577.
19. Lucas, B., and R. N. Germain. 2000. Opening a window on thymic positive selection: developmental changes in the influence of cosignaling by integrins and CD28 on selection events induced by TCR engagement. J. Immunol. 165:1889.
20. Foy, T. M., D. M. Page, T. J. Waldschmidt, A. Schoneveld, J. D. Laman, S. R. Masters, L. Tygrett, J. A. Ledbetter, A. Aruffo, E. Claassen, et al. 1995. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182:1377.
21. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745.
22. Acha-Orbea, H., and H. R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13:459.
23. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
24. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Shcweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
25. Mandelbrot, D. A., M. A. Oosterwegel, K. Shimizu, G. J. Freeman, R. N. Mitchell, and A. H. Sharpe. 2001. B7-dependent T cell costimulation in mice lacking CD28 and CTLA4. J. Clin. Invest. 107:881.
26. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27.
27. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
28. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
29. Gao, J. X., H. Zhang, X. F. Bai, J. Wen, X. Zheng, J. Liu, P. Zheng, and Y. Liu. 2002. Perinatal blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J. Exp. Med. 195:959.
30. Acha-Orbea, H., W. Held, G. A. Waanders, A. N. Shakhov, L. Scarpellino, R. K. Lees, and H. R. MacDonald. 1993. Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol. Rev. 131:5.
31. + thymocytes. J. Exp. Med. 190:943.
32. Turka, L. A., P. S. Linsley, R. Paine III, G. L. Schieven, G. B. Thompson, and J. A. Ledbetter. 1991. Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes: implications for thymic selection. J. Immunol. 146:1428.
33. Nelson, A. J., S. Hosier, W. Brady, P. S. Linsley, and A. G. Farr. 1993. Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro. J. Immunol. 151:2453.
34. Reiser, H., and E. E. Schneeberger. 1994. The costimulatory molecule B7 is expressed in the medullary region of the murine thymus. Immunology 81:532.
35. Inaba, L., M. Witmer-Pack, M. Inaba, K. S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P. S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849.
36. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
37. + thymocytes. Med. Microbiol. Immunol. 187:49.
38. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116.
39. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29.
40. + T cells. J. Immunol. 165:5035.
41. Brodie, D., A. V. Collins, A. Iaboni, J. A. Fennelly, L. M. Sparks, X. N. Xu, P. A. van der Merwe, and S. J. Davis. 2000. LICOS, a primordial costimulatory ligand? Curr. Biol. 10:333.
42. Mages, H. W., A. Hutloff, C. Heuck, K. Buchner, H. Himmelbauer, F. Oliveri, and R. A. Kroczek. 2000. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur. J. Immunol. 30:1040.
43. -) thymocytes. Int. Immunol. 8:773.
44. Nishimura, H., T. Honjo, and N. Minato. 2000. Facilitation of β selection and modification of positive selection in the thymus of PD-1-deficient mice. J. Exp. Med. 191:891.
45. , Williams, J. A., S. O. Sharrow, A. J. Adams, and R. J. Hodes. 2002. CD40 ligand functions non-cell autonomously to promote deletion of self-reactive thymocytes. J. Immunol. 168:2759.
46. Caux, C., N. Burdin, L. Galibert, P. Hermann, N. Renard, C. Servet-Delprat, and J. Banchereau. 1994. Functional CD40 on B lymphocytes and dendritic cells, Res. Immunol. 145:235.
47. Caux. C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
48. Manickasingham, S., and C. Reis e Sousa. 2000. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165:5027.
49. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimoyama, C. Reis e Sousa, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927.
50. Ardavin, C., G. Waanders, I. Ferrero, F. Anjuere, H. Acha-Orbea, and H. R. MacDonald. 1996. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells. J. Immunol. 157:2789.
51. Mazda, O., Y. Watanabe, J. Gyotoku, and Y. Katsura. 1991. Requirement of dendritic cells and B cells in the clonal deletion of Mls-reactive T cells in the thymus. J. Exp. Med. 173:539.
52. Yamada, A., K. Kishimoto, V. M. Dong, M. Sho, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, H. Auchincloss, and M. H. Sayegh 2001. CD28 independent costimulation of T cells in alloimmune responses. J. Immunol. 167:140.